Published in
Elsevier, Multiple Sclerosis and Related Disorders, (55), p. 103157, 2021
DOI: 10.1016/j.msard.2021.103157
Links
Tools
T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers
Journal article published in 2021 by
Marco Iannetta,
Doriana Landi,
Gaia Cola 
,
Vincenzo Malagnino,
Elisabetta Teti,
Daniela Fraboni,
Francesco Buccisano,
Sandro Grelli,
Luigi Coppola,
Laura Campogiani,
Massimo Andreoni,
Girolama Alessandra Marfia,
Loredana Sarmati
,
Vincenzo Malagnino,
Elisabetta Teti,
Daniela Fraboni,
Francesco Buccisano,
Sandro Grelli,
Luigi Coppola,
Laura Campogiani,
Massimo Andreoni,
Girolama Alessandra Marfia,
Loredana Sarmati
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 